$10.37
-0.17-1.61%
At close: -
$10.38
0.010.10%
After Hours: 7:16 PM EDT
Comments
Loading...
Latest EyePoint Pharmaceuticals Stock News | NASDAQ:EYPT | Benzinga
Get the latest news on EyePoint Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on EyePoint Pharmaceuticals performance
Categories: All
Tuesday, June 17, 2025
Thursday, May 29, 2025
Wednesday, May 28, 2025
Tuesday, May 27, 2025
Friday, May 16, 2025
Thursday, May 08, 2025
Wednesday, May 07, 2025
Tuesday, May 06, 2025
Friday, March 14, 2025
Thursday, March 06, 2025
Wednesday, March 05, 2025
Thursday, February 20, 2025
Tuesday, February 18, 2025
Thursday, February 06, 2025
Wednesday, February 05, 2025
Monday, January 13, 2025
Tuesday, January 07, 2025
Thursday, December 05, 2024
Wednesday, December 04, 2024
Monday, November 11, 2024
Friday, November 08, 2024
Wednesday, October 30, 2024
Tuesday, October 29, 2024
Monday, October 28, 2024
- EyePoint Pharmaceuticals Commencea Public Off...
- 12 Health Care Stocks Moving In Monday's Intraday Session
- EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss
- PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
- EyePoiint Pharmaceuticals shares are trading ...
- EyePoint's DURAVYU Shows Results for Diabetic...
